ChemPartner PharmaTech Co

ChemPartner PharmaTech Co Intangible Assets

The Intangible Assets of ChemPartner PharmaTech Co (300149.SZ) as of Oct 27, 2026 is 30.66 M CNY. In the previous year, Intangible Assets was 30.05 M CNY — a change of 2.04% (higher).

Intangible Assets

30.66 MCNY

YoY

2.04%

Last updated:

Intangible Assets of ChemPartner PharmaTech Co is 2024 30.66 M CNY. Intangible Assets of ChemPartner PharmaTech Co was 2023 30.05 M CNY. It decreases by 2.04% higher compared to the previous year.

The ChemPartner PharmaTech Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
43.20 M CNY
Jan 1, 2018
212.30 M CNY
Jan 1, 2019
192.50 M CNY
Jan 1, 2020
165.00 M CNY
Jan 1, 2021
148.61 M CNY
Jan 1, 2022
55.66 M CNY
Jan 1, 2023
30.05 M CNY
Jan 1, 2024
30.66 M CNY
The ChemPartner PharmaTech Co Intangible Assets history
YEARIntangible AssetsYoY
30.66 MCNY+2.04%
30.05 MCNY-46.01%
55.66 MCNY-62.55%
148.61 MCNY-9.93%
165.00 MCNY-14.29%
192.50 MCNY-9.33%
212.30 MCNY+391.44%
43.20 MCNY-4.21%
45.10 MCNY-3.84%
46.90 MCNY-2.29%
48.00 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ChemPartner PharmaTech Co Stock analysis

What does ChemPartner PharmaTech Co do? ChemPartner PharmaTech Co., Ltd. generates revenue through the research, development, production, and sale of prebiotic products, primarily fructooligosaccharides and galactooligosaccharides. The company markets its products under the brand names FOS and GOS, targeting the nutrition and health, dairy, beverage, bakery, and functional snack food industries. Domestic distribution dominates, with South China as the core market, serving manufacturers of food and health products. The firm's product portfolio focuses on fructooligosaccharides and galactooligosaccharides, sold as FOS and GOS, which are integrated into various consumer goods. These prebiotics are essential ingredients in dairy, beverages, baked goods, and functional snacks, meeting demand from food producers seeking health-enhancing additives. South China remains the primary sales region, aligning with the company's domestic market strategy. ChemPartner PharmaTech's revenue streams derive from B2B sales to food and beverage manufacturers, particularly those producing nutrition and health products, dairy, and functional snacks. The company's brands FOS and GOS are positioned as key ingredients for health-focused consumer goods, with sales concentrated in South China, the main market for its domestic distribution network. ChemPartner PharmaTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ChemPartner PharmaTech Co stock

Intangible Assets of ChemPartner PharmaTech Co is 30.66 M CNY in 2024.

Intangible Assets of ChemPartner PharmaTech Co changed from 30.05 M CNY to 30.66 M CNY, representing a 2.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets ChemPartner PharmaTech Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's ChemPartner PharmaTech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ChemPartner PharmaTech Co

All Key Metrics — ChemPartner PharmaTech Co